Log in to save to my catalogue

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9165287

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

About this item

Full title

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of nuclear medicine and molecular imaging, 2022-06, Vol.49 (7), p.2377-2391

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Accurate glioma classification affects patient management and is challenging on non- or low-enhancing gliomas. This study investigated the clinical value of different chemical exchange saturation transfer (CEST) metrics for glioma classification and assessed the diagnostic effect of the presence of abundant fluid in glioma subpopulations...

Alternative Titles

Full title

CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9165287

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9165287

Other Identifiers

ISSN

1619-7070,1619-7089

E-ISSN

1619-7089

DOI

10.1007/s00259-022-05676-1

How to access this item